Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Inclusion Body Myositis (sIBM)”

4 trials

Showing 4 of 4 results

Very early researchLooking for participantsNCT06479863
What this trial is testing

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)Idiopathic Inflammatory Myopathies
Austin Neuromuscular Center 10
Large-scale testing (Phase 3)Study completedNCT01925209
What this trial is testing

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients

Who this might be right for
Sporadic Inclusion Body Myositis
Novartis Pharmaceuticals 251
Large-scale testing (Phase 3)Study completedNCT02250443
What this trial is testing

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)
Novartis Pharmaceuticals 10
Not applicableUnknownNCT02735447
What this trial is testing

Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study

Who this might be right for
Sporadic Inclusion Body Myositis
La-ser Europe Limited 190

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation